Core Outcome Set–STAndards for Reporting: The COS-STAR Statement
Open accessThe DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Core outcome sets (COS) can enhance the relevance of research by ensuring that outcomes of importance to health service users and other people making choices about health care in a particular topic area are measured routinely. Over 200 COS to date have been developed, but the clarity of these reports is suboptimal. COS studies will not achieve their goal if reports of COS are not complete and transparent. METHODS AND FINDINGS: In recognition of these issues, an international group that included experienced COS developers, methodologists, journal editors, potential users of COS (clinical trialists, systematic reviewers, and clinical guideline developers), and patient representatives developed the Core Outcome Set-STAndards for Reporting (COS-STAR) Statement as a reporting guideline for COS studies. The developmental process consisted of an initial reporting item generation stage and a two-round Delphi survey involving nearly 200 participants representing key stakeholder groups, followed by a consensus meeting. The COS-STAR Statement consists of a checklist of 18 items considered essential for transparent and complete reporting in all COS studies. The checklist items focus on the introduction, methods, results, and discussion section of a manuscript describing the development of a particular COS. A limitation of the COS-STAR Statement is that it was developed without representative views of low- and middle-income countries. COS have equal relevance to studies conducted in these areas, and, subsequently, this guideline may need to evolve over time to encompass any additional challenges from developing COS in these areas. CONCLUSIONS: With many ongoing COS studies underway, the COS-STAR Statement should be a helpful resource to improve the reporting of COS studies for the benefit of all COS users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The protocol followed the COS-STAP statement (Kirkham et al., 2019), and the process followed modifications of the COS-STAD guidelines (Kirkham et al., 2016) and the COMET and OMERACT handbooks (Beaton et al., 2021;Williamson et al., 2017).”
From Relevant domains, core outcome sets and measurements for implant dentistry clinical trials: The Implant Dentistry Core Outcome Set and Measurement ( ID‐COSM) international consensus report (2023) · cites this paper as Kirkham et al., 2016
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The study protocol was published a priori 19 , along with the registration of VAPAIN in the Core Outcome Measures in Effectiveness Trials (COMET) database 7 .”
From Developing a core outcome domain set to assessing effectiveness of interdisciplinary multimodal pain therapy: the VAPAIN consensus statement on core outcome domains (2018) · cites this paper as [19]
Experimental — accuracy not yet measuredIn the citing paper
“1. IMPT patients have protracted, and ongoing, pain. Pain interferes with most life domains, thus changes in biopsychosocial aspects need to be considered when assessing therapies.”
In the citing paper
“2. The primary aim of IMPT is not reduction of pain in the first instance, but focusing on general improvements in physical, psychological, and social aspects according to patients' experience.”
In the citing paper
“The development process of this COS has been reported according to the Core Outcome Set – Standards for Reporting Statement (COS-STAR) (14).”
From Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot Ulceration (2024) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · cited 1×
“It follows a similar format to that used in other explanatory documents [10,11].”
MethodSelf-citationLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Self-citationCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Self-citationLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Self-citationCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
Self-citationMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Self-citationCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000251 · Cited by 2,296
Self-citationReddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L.-P., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P. L., Gibson, P. G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-060st · Cited by 1,918
Developing core outcome sets for clinical trials: issues to consider
Williamson, P. R., Altman, D. G., Blazeby, J. M., Clarke, M., Devane, D., Gargon, E., & Tugwell, P. (2012) · Trials · doi:10.1186/1745-6215-13-132 · Cited by 1,661
Self-citationGuidance for Developers of Health Research Reporting Guidelines
Moher, D., Schulz, K. F., Simera, I., & Altman, D. G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000217 · Cited by 1,437
Self-citation
Cited by
Items 301–400 of 643
Core outcome set for perinatal interventions for congenital diaphragmatic hernia
Vergote, S., Bie, F. R. D., Duffy, J. M., Bosteels, J. J. A., Benachi, A., Power, B., de Meijer, F., Hedrick, H. L., Fernandes, C. J., Reiss, I. K. M., et al. (2023) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26235 · Cited by 9
Bravington, A., Obita, G., Baddeley, E., Johnson, M. J., Murtagh, F. E., Currow, D. C., Boland, E. G., Nelson, A., Seddon, K., Oliver, A., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289501 · Cited by 10
A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema
Petersen, R. S., Fijen, L. M., Apfelbacher, C., Magerl, M. A. K., Weller, K., Aberer, W., Adatia, A., Audhya, P., Bara, N., Betschel, S., et al. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.04.007 · Cited by 10
“A steering group consisting of members from these initiative centers was formed, composed of six clinicians and clinical researchers (R.S.”
BackgroundZambrano, S. C., Egloff, M., González-Jaramillo, V., Christen, A., Allan, S. G., Barnestein‐Fonseca, P., Ellershaw, J., Fischer, C., Haugen, D. F., Lunder, U., et al. (2024) · Palliative Medicine · doi:10.1177/02692163241300867 · Cited by 9
Self-citationAzarpazhooh, A., Zanjir, M., Cardoso, E., Harman, N., Khansari, A., Jafarzadeh, H., Malkhassian, G., Sabeti, M., Aminoshariae, A., Kishen, A., et al. (2025) · Journal of Endodontics · doi:10.1016/j.joen.2025.01.008 · Cited by 10
Zanjir, M., Cardoso, E., Harman, N., Khansari, A., Jafarzadeh, H., Malkhassian, G., Sabeti, M., Aminoshariae, A., Kishen, A., Sale, J. E. M., et al. (2025) · Journal of Endodontics · doi:10.1016/j.joen.2025.01.009 · Cited by 11
Reducing waste in pediatric clinical research
Kassaï, B., Glais, F., Grenet, G., Cornu, C., & Nguyen, K. A. (2018) · Therapies · doi:10.1016/j.therap.2017.11.013 · Cited by 10
Kang, B. Y., Ibrahim, S. A., Shokeen, D., Schlessinger, D. I., Kirkham, J. J., Schmitt, J. M., Poon, E., Maher, I. A., Sobanko, J. F., Cartee, T. V., et al. (2021) · Archives of Dermatological Research · doi:10.1007/s00403-021-02239-6 · Cited by 10
Self-citationDevelopment of a Core Outcome Set for Children Aged 1-18 Years with Gastroesophageal Reflux Disease
Rexwinkel, R., Henegouwen, V. W. A. V. B., Singendonk, M. M. J., Krishnan, U., Vandenplas, Y., Strisciuglio, C., Rosen, R., Lalanne, A., Rajindrajith, S., Benninga, M. A., et al. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.01.043 · Cited by 9
Wei, W., Tan, B., Yan, Y., Li, W., Zeng, X., Chen, Q., Wang, R., He, H., Qin, L., Li, T., et al. (2023) · Orthopaedic Surgery · doi:10.1111/os.13639 · Cited by 9
Brocklehurst, P. R., Langley, J., Baker, S. R., McKenna, G. J., Smith, C. J., & Wassall, R. R. (2019) · BDJ · doi:10.1038/s41415-019-0458-5 · Cited by 10
Sanz, M., Carrillo de Albornoz, A., Martín, C., Needleman, I., & Tonetti, M. S. (2023) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13805 · Cited by 8
“In the present study, we have applied the Core Outcome Set-STAndards (COS-STAD) guideline to drive consensus by first under-taking a Delphi-based project to agree on a set of outcome areas that could be further discussed for the final COS development.”
BackgroundInfluentialManderlier, B., von Kemp, B. A., Beeckman, K., Cosyns, B., den Bussche, K. V., panel, C.-O. E., Clark, R. A., Foote, J. W., Hendriks, J., Gevaert, S., et al. (2024) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcae038 · Cited by 8
A common outcome set for trials in dementia with Lewy bodies (DLB COS)
Kane, J. P. M., Fitzpatrick, R. L., Betzhold, S. M., Daly, G., Kalfas, E., Kinchin, I., Aarsland, D., Greaney, K., Grycuk, E., Folkerts, A., et al. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70134 · Cited by 8
Stricker, P. A., Vutskits, L., de Graaff, J. C., von Ungern-Sternberg, B. S., Goobie, S. M., Zuo, Y., Ramos, T. A., Meyer, H. M., Taylor, E., Whyte, S. D., et al. (2025) · Anesthesiology · doi:10.1097/aln.0000000000005693 · Cited by 10
Pidgeon, T. E., Omran, Y. A., Farwana, R., Phan, K. H., Al-Dulaimy, B., Radhakrishnan, A., Kurar, L., Szczap, A., & Sujan, M. A. (2020) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000006680 · Cited by 8
Richardson, E., McEwen, A., Newton-John, T. R. O., Manera, K., & Jacobs, C. (2021) · Trials · doi:10.1186/s13063-021-05439-7 · Cited by 10
Pease, A. S., Goodenough, T., Borwick, C., Watanabe, R., Morris, C., & Williams, C. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051014 · Cited by 8
“6 Guidelines exist to aid researchers in developing COS::Core outcome Set-STAndards for development (CO-STAD 7 ) and reporting processes: Core outcome Set-STAndards for reporting (CO-STAR 8 ), which we have followed insofar as our resources allowed.”
Beecher, C., Duane, S., Vellinga, A., Murphy, A. W., Cormican, M., Smyth, A., Healy, P., Moore, M. V., Little, P. S., Geoghegan, C., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11121846 · Cited by 10
“The findings are reported here in line with the Core Outcome Set-STAndards for Reporting statement (COS STAR) [16].”
ResultSelf-citationGelbard, R. B., Nahmias, J. T., Byerly, S. E., Ziesmann, M. T., Stein, D. M., Haut, E. R., Smith, J. W., Boltz, M. M., Zarzaur, B. L., Callum, J., et al. (2023) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003884 · Cited by 8
“com/TA/C848, covers the minimum reporting requirements related to the background, scope, methods, results, conclusion, and limitations of such studies.(13) The study was registered with the Core Outcome Measures in Effectiveness Trials database(14) and carried out under the oversight of the EAST COS Task Force.”
MethodRetzer, A., Baddeley, E., Sivell, S., Scott, H. R., Nelson, A., Bulbeck, H., Seddon, K., Grant, R., Adams, R., Watts, C., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad096 · Cited by 13
Manduchi, B., Fitch, M. I., Ringash, J. G., Howell, D., & Martino, R. (2024) · Head & Neck · doi:10.1002/hed.27626 · Cited by 8
“In line with the COMET guidelines, 17 this study adhered to the COS-STAR statement 29 and was registered in the COMET database.”
MethodOlayinka, A., Bourner, J., Akpede, G. O., Okoeguale, J., Abejegah, C., Ajayi, N. A., Akude, C., Ayodeji, O. O., Bausch, D. G., Clerck, H. D., et al. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010089 · Cited by 10
Rowe, F. J., Hepworth, L. R., & Kirkham, J. J. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056792 · Cited by 9
Self-citationAquilina, A. L., Claireaux, H. A., Aquilina, C. O., Tutton, E., Fitzpatrick, R. M., Costa, M. L., & Griffin, X. L. (2023) · Bone and Joint Research · doi:10.1302/2046-3758.124.bjr-2022-0164.r2 · Cited by 8
Jacobson, M. E., Rick, J. W., Gerbens, L. A. A., Baghoomian, W., Gould, L. J., Marzano, A. V., Chen, D. M., Oakes, D. L., Dissemond, J., Yamamoto, T., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad420 · Cited by 9
van Miert, C., Fernandes, R. M., Eccleson, H., Bedson, E., Lane, S., Peak, M., Thorburn, K., Compton, V., Woolfall, K., Lacy, D., et al. (2018) · Trials · doi:10.1186/s13063-018-2969-9 · Cited by 9
Self-citationChristoforou, A., Armstrong, M. J., Bergin, M. J. G., Robbins, A., Merillat, S. A., Erwin, P. J., Getchius, T. S. D., McCrea, M., Markowitz, A. J., Manley, G. T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242811 · Cited by 9
“• Only studies meeting accepted standards for high-quality methodology [20, 22, 24, 25] should qualify for evidentiary review”
BackgroundBaker, S. R., Heaton, L. J., & McGrath, C. P. J. (2023) · Community Dentistry And Oral Epidemiology · doi:10.1111/cdoe.12821 · Cited by 11
The need for core outcome sets in urological cancer research
MacLennan, S., & Williamson, P. R. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-1323 · Cited by 9
“Finally, the COS is usually reported in a journal manuscript and reporting according to the Core Outcome Set Standards for Reporting (COS-STAR) statement (13) is encouraged.”
Self-citationA meta-core outcome set for stillbirth prevention and bereavement care following stillbirth in LMIC
Dube, K., Marenga, F., Ayebare, E. O., Bedwell, C., Chaudhry, N., Chilinda, I., Chimwaza, A. F., Devane, D., Fattepur, S., Goshomi, U., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-017688 · Cited by 7
Self-citationRoijer, P. J., Vallinga, M. S., Pidgeon, T. E., Angelini, M., Ceulemans, A., Bakker, A., Carrière, B., Rashid, T. G., Bellringer, J., Belinky, J., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103325 · Cited by 7
“6,9,17 While the current study has followed these standards and recommendations, several methodological findings and aspects warrant discussion (see also Supplementary Material, Chapter 3).”
Demetri, A., Davies, A. K., Bakhbakhi, D., Ijaz, S., Dawson, S., McGuinness, S., Beasor, G., Clayton, G., Johnson, A., de Souza, C., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-070215 · Cited by 8
Husson, O., Janssen, S. H. M., Reeve, B. B., Sodergren, S. C., Cheung, C. K., McCabe, M. G., Salsman, J. M., van der Graaf, W. T. A., & Darlington, A. (2024) · BMC Cancer · doi:10.1186/s12885-023-11716-2 · Cited by 7
“The development of this COS for AYAs will be reported according to the COS-STAR (Core Outcome Set-STAndards for Reporting) guidelines [31].”
MethodThe development of a core outcome set for crisis helplines: A three-panel Delphi study
Curll, S. L., Mazzer, K., & Rickwood, D. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100763 · Cited by 8
Development of a core outcome set for treatment studies for provoked vestibulodynia
Bohm‐Starke, N., Pukall, C. F., Österberg, M., Ahlberg, M., Jonsson, A. K., Tranæus, S., Kempe, S., & Hellberg, C. (2024) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdae035 · Cited by 9
Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement
Dirr, M. A., Ahmed, A., Schlessinger, D. I., Haq, M., Shi, V. J., Koza, E., Ma, M. J., Christensen, R. E., Ibrahim, S. A., Schmitt, J. M., et al. (2024) · JAMA Dermatology · doi:10.1001/jamadermatol.2024.0636 · Cited by 7
Self-citationAlanazi, S. A., Vicenzino, B., van Bergen, C. J. A., Hunter, D. J., Wikstrom, E. A., Menz, H. B., Golightly, Y. M., & Smith, M. D. (2024) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2024.07.004 · Cited by 9
Inhaled analgesics for the treatment of prehospital acute pain—A systematic review
Hyldmo, P. K., Rehn, M., Friesgaard, K. D., Rognås, L. K., Raatiniemi, L., Kurola, J. O., Larsen, R., Kongstad, P., Sandberg, M., Magnússon, V., et al. (2024) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.14527 · Cited by 7
Informing Decision‐Making About Caesarean Birth: A Delphi Study to Develop a Core Information Set
Kingdon, C., Greenfield, B., Aljubeh, M., Bunni, E., Hunt, A., Bradley, V., Cunningham, C., Holt, S., Demetri, A., Burden, C., et al. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18269 · Cited by 7
“Adapted Core Outcome Set–STAndards for reporting (COS-STAR) were used [34].”
A systematic review of outcome reporting in laser treatments for dermatological diseases
Fransen, F., Tio, D., Prinsen, C. A. C., Hædersdal, M., Hedelund, L., Laubach, H., Marini, L., Paasch, U., Passeron, T., & Wolkerstorfer, A. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15928 · Cited by 8
Maga, G., Brigante, L., Bo, E. D., Cappadona, R., Daniele, M., Arrigoni, C., Caruso, R., & Magon, A. (2022) · Midwifery · doi:10.1016/j.midw.2022.103292 · Cited by 10
Defining core patient descriptors for perforated peptic ulcer research: international Delphi
collaborators, P. C., Lamidi, S., Williams, K. M., Hind, D., Peckham-Cooper, A., Miller, A. S., Smith, A. M., Saha, A. K., Macutkiewicz, C., Griffiths, E. A., et al. (2022) · British journal of surgery · doi:10.1093/bjs/znac096 · Cited by 7
Ram, B., Foley, K., van Sluijs, E. M. F., Hargreaves, D. S., Viner, R., & Saxena, S. K. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061335 · Cited by 8
Karim, I. A. E., Duncan, H. F., Nagendrababu, V., & Clarke, M. J. (2022) · International Endodontic Journal · doi:10.1111/iej.13862 · Cited by 10
Self-citationHeterogeneity of surrogate outcome measures used in critical care studies: A systematic review
Verghis, R. M., Blackwood, B., McDowell, C., Toner, P. G., Hadfield, D., Gordon, A. C., Clarke, M. J., & McAuley, D. F. (2023) · Clinical Trials · doi:10.1177/17407745231151842 · Cited by 9
Self-citationAgar, M. R., Siddiqi, N., Hosie, A., Boland, J. W., Johnson, M. J., Featherstone, I., Lawlor, P. G., Bush, S. H., Page, V. J., Amgarth‐Duff, I., et al. (2021) · Palliative Medicine · doi:10.1177/02692163211040186 · Cited by 7
Development of a core outcome set for basal cell carcinoma
Schlessinger, D. I., Reynolds, K. A., Dirr, M. A., Ibrahim, S. A., Yanes, A. F., Lazaroff, J. M., Godinez-Puig, V., Chen, B. R., Kurta, A. O., Cotseones, J. K., et al. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.04.059 · Cited by 7
Self-citationLiu, M., Gao, Y., Yuan, Y., Shi, S., Yang, K., Lu, C., Wu, J., Zhang, J., & Tian, J. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.11.009 · Cited by 7
Thompson, W., Howe, S., Pitkeathley, C., Coull, C., & Teoh, L. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057934 · Cited by 9
Zanjir, M., Cardoso, E., Harman, N. L., Khansari, A., Jafarzadeh, H., Malkhassian, G., Sabeti, M., Aminoshariae, A., Kishen, A., Sale, J. E. M., et al. (2025) · Journal of Endodontics · doi:10.1016/j.joen.2025.01.011 · Cited by 6
Lee, N., Smith, C. E., Bailey, R. L., Ariyoshi, K., Smith, S. C., Black, N. A., & Edwards, T. (2025) · Trials · doi:10.1186/s13063-024-08713-6 · Cited by 6
Altenburg, T. M., de Vries, L. W., Barbeau, K., Button, A. M., Cox, A., de Lannoy, L., MacDonald, M. J., Naidoo, R., Staiano, A. E., Tremblay, M. S., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1519467 · Cited by 6
“…Likert scale using the traffic light system where red corresponds with a score of 1–3 (not important), orange with a score of 4–6 (important) and green with a score of 7–9 (very important), which is the approach previously used by Kirkham et al. (17, 18), Harman et al. (13), and Reilly et al. (19).”
Core Outcome Sets for Studies of Diabetes in Pregnancy: A Review
Egan, A. M., Bogdanet, D., Biesty, L., Kgosidialwa, O., McDonagh, C., O'Shea, C., O’Shea, P. M., Devane, D., & Dunne, F. (2020) · Diabetes Care · doi:10.2337/dc20-1621 · Cited by 9
Self-citationvan Schaik, T. J. A., Pouw, M. H., Curt, A. E. P., van Nes, I. J. W., der Hulst, M. V.-V., & van Hooff, M. L. (2022) · Spinal Cord · doi:10.1038/s41393-022-00792-z · Cited by 6
“The recommendations from the Guidance on Conducting and Reporting Delphi Studies (CREDES) [26] and the Core Outcome Set standards for reporting (COS-STAR Statement) were used to report the study findings [27].”
MethodLangbroek, G. B., Wolkerstorfer, A., Horbach, S. E. R., Spuls, P. I., Kelly, K. M., Robertson, S. J., van Raath, M. I., Al‐Niaimi, F., Kono, T., Boixeda, P., et al. (2022) · British Journal of Dermatology · doi:10.1111/bjd.21723 · Cited by 6
Kim, P.-W., Kim, S., Kim, D., Cha, J., Lee, H.-S., Ko, M. M., Jang, S., Yang, C., & Lee, M. S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192215321 · Cited by 6
“We followed the development process of a COS reported by the COMET initiative and COS standard guidelines [18].”
MethodMunce, S., Wong, E., Luong, D., Rao, J., Cunningham, J., Bailey, K., John, T., Barber, C. E. H., Batthish, M., Chambers, K., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080822 · Cited by 7
“73 74 For example, it may provide a rationale for including checklist items for reporting patient involvement beyond being participants.”
BackgroundRyan, J., Devane, D., Simiceva, A., Eppich, W., Kavanagh, D. O., Cullen, C., Hogan, A. M., & McNamara, D. A. (2024) · Trials · doi:10.1186/s13063-024-08201-x · Cited by 6
“…been developed according to the Core Outcome Measures in Effectiveness Trials (COMET) initiative guidance for core outcome set development [8] and will be conducted and reported following the Core Outcome Set-Standards for Development (COS-STAD) [11] and Reporting (COS-STAR) [12] recommendations.”
MethodSelf-citationHamzeh, H., Kelly, C. A., Lee, A. L., Spinou, A., Marques, A. S. P. D. D., Herrero‐Cortina, B., Burtin, C., Hall, K., & Spencer, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34101 · Cited by 5
“The study followed the Core Outcome Set-Standards for Reporting (COS-STAR) Statement [16].”
MethodDevelopment of a core descriptor set for parastomal hernia repair
Blackwell, S., Massey, L. H., Mehta, A., Smart, N. J., Sahnan, K., Lederhuber, H., & Lee, M. J. (2024) · Colorectal Disease · doi:10.1111/codi.17151 · Cited by 6
“It was developed with reference to the COS-STAD guidelines [ 13] and reported using COS-STAR guidelines [ 14].”
Fang, G., Yu, W., Chen, D., Ding, X., Qiao, L., Zhang, L., Gao, X., Yan, Y., Huang, Q., Ma, J., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-083315 · Cited by 6
An E-Delphi study to facilitate animal welfare assessment in Italian zoos and aquaria
de Mori, B., Mercugliano, E., Cerizza, A. F., Biasetti, P., Florio, D., Re, R. D., Mazzariol, S., Usachova, O., Basile, S., Gili, C., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0309760 · Cited by 7
Wilson, A., Bedwell, C., Danna, V. A., Tate, N., Dwan, K. M., Portela, A. G., & Lavender, T. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0005690 · Cited by 7
“This suggests that, for this area of investigation, development of core outcome sets and consensus of key outcome measurement points would be valuable, to enable consensus on a standardised minimal group of important outcomes [89].”
O’Malley, N., Coote, S. B., & Clifford, A. M. (2021) · HRB Open Research · doi:10.12688/hrbopenres.13459.1 · Cited by 6
Mitchell, C., Bowen, A., Conroy, P., Whelan, B., Wallace, S. J., Dancer, A., Woodward‐Nutt, K., & Kirkham, J. J. (2023) · Trials · doi:10.1186/s13063-022-06958-7 · Cited by 7
“We will report the development of this COS-Speech according to the COS-STAR (Core Outcome Set-STandards for Reporting) guidelines [25].”
MethodSelf-citationThe core outcomes for open lower limb fracture study: how should core outcomes be measured?
Aquilina, A. L., Claireaux, H., Aquilina, C. O., Tutton, E., Fitzpatrick, R. M., Costa, M. L., & Griffin, X. L. (2023) · Bone and Joint Research · doi:10.1302/2046-3758.126.bjr-2022-0280.r1 · Cited by 6
Sun, Y., An, Y., Weng, Z., Zhou, Y.-J., Wang, X., & Yu, C. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075856 · Cited by 6
“Moreover, the results of the SLR were partly published to assess the effectiveness of non-pharmaceutical Chinese medical therapies alone or in combination for the treatment of LSS. 18”
BackgroundQiu, R., Wan, S., Zhong, C., Han, S., He, T., Huang, Y., Wei, X., Li, M., Guan, Z., Zhang, X., et al. (2024) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12579 · Cited by 8
Doelare, S. A. N., Oukrich, S., Yeung, K. K., Hinchliffe, R. J., Jongkind, V., Tran, B. L., Knaapen, M., Catarinella, F. S., & de Vries, R. (2024) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2024.07.042 · Cited by 7
Peritoneal dialysis access outcomes reported in randomized controlled trials: A systematic review
Elbokl, M., Momciu, B., Kishibe, T., Oliver, M. J., & Perl, J. M. (2020) · Peritoneal Dialysis International · doi:10.1177/0896860820966898 · Cited by 6
“There is growing evidence that heterogeneity in outcome selection and outcome measures strongly impacts interpretation of study conclusions and limits their utility.(4,5) Such variability makes the conduct of systematic reviews or meta-analysis difficult while limiting the interpretation of the effectiveness of the in…”
BackgroundCha, J., Kim, S., Kim, P.-W., Lee, H., Ko, M. M., Jang, S., & Lee, M. S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868662 · Cited by 7
“The COS development process was guided by the COMET initiative and reported based on the COS standard guidelines (Cadogan et al., 2015; Kirkham et al., 2016; Rankin et al., 2018).”
MethodInterventions in Acute Intracranial Surgery: An Evidence-Based Perspective
Post, R., Germans, M. R., Buis, D. R., Coert, B. A., Vandertop, W. P., & Verbaan, D. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2022.02.049 · Cited by 6
Sheng, X., Chen, C., Ji, Z., Hu, H., Zhang, M., Wang, H., Pang, B., Zhai, J., Zhang, D., Zhang, J., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062497 · Cited by 7
Dube, K., Ayebare, E., Bakhbakhi, D., Bedwell, C., Chandriah, S., Chaudhry, N., Chilinda, I., Chimwaza, A., Goshomi, U., Laisser, R., et al. (2022) · medRxiv · doi:10.1101/2022.10.13.22281030 · Cited by 6
“In country ethics was also obtained from each of the eight participating countries The development of these COS will be reported according to the COS-STAR (Core Outcome Set-STAndards for Reporting) guidelines [16].”
MethodSelf-citationFontaine, G., Michie, S., Beidas, R. S., Geng, E. H., Fahim, C., Powell, B. J., Welch, V. N., Thomas, J., Chan, J., Abbasgholizadeh-Rahimi, S., et al. (2026) · Implementation Science · doi:10.1186/s13012-026-01503-5 · Cited by 7
“The eDelphi will be designed and reported in accordance with CREDES recommenda - tions [61], and the core outcome set component will be informed by COMET-aligned standards [86, 87].”
Mansukoski, L., Albert, A. E., Vafai, Y., Cartwright, C., Rahman, A., Sheringham, J., Lockyer, B., Yang, T., Garnett, P., & Bryant, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19137947 · Cited by 7
“The COS development was registered on the COMET website (#1910) and the reporting of the study is in line with the COS-STAR Statement [13,14].”
MethodSmith, N. L., Gibson, N., Imms, C., Thornton, A., & Harvey, A. R. (2025) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.16325 · Cited by 5
“The proposed COS was registered on the Core Outcome Measures in Effectiveness Trials database; 19 the Core Outcome Set-STAndards for development 15 and reporting 20 was used.”
Development of a clinical core outcome set to evaluate lung cancer rehabilitation
Edbrooke, L., Davies, T., Granger, C. L., Halloran, E., John, T., Connolly, B. A., Denehy, L., & Collaborative, T. L. C. R. (2025) · ERJ Open Research · doi:10.1183/23120541.00058-2025 · Cited by 6
“…study was developed and conducted with guidance from the Core Outcome Measures in Effectiveness Trials (COMET) handbook [15] and the Core Outcome Set-Standards for Development (COS-STAD) recommendations [16] and is reported according to the Core Outcome Set-Standards for Reporting (COS-STAR) [17].”
Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of life
Rönsch, H., Drewitz, K. P., Atwater, A. R., Becker, D., Bentz, P., Brans, R., Chong, T. Y. R., Dickel, H., Elsner, P. U., Giménez‐Arnau, A. M., et al. (2025) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20671 · Cited by 5
“We report our results according to the COS-STAR (Core Outcome Set-STAndards for Reporting) guideline and the checklist by Sinha et al. 9,10”
Hirschwald, J., Conroy, P., Boyle, G., Warnecke, T., & Walshe, M. (2025) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2024-113543 · Cited by 5
“25 The Core Outcome Set-STAndards for Reporting 26 and the Accurate Consensus Reporting Document 27 guidelines were used in this manuscript to report the study.”
A Core Outcome Set for Stillbirth Care: An International Consensus Study
Bakhbakhi, D., Davies, A. K., Siassakos, D. M., Hinton, L., Duffy, J. M., Dangerfield, H., Redshaw, M., Merriel, A., Howell, A., Heazell, A. E. P., et al. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18265 · Cited by 6
“…with the Core Outcome Measures in Effectiveness Trials (COMET) Initiative (registration number 775 [14]), developed with reference to the Core Outcome Set-STAndards for Development (COS-STAD) and reported using the Core Outcome Set-STAndards for Reporting as reference [15, 16] (See Appendix S1).”
Moghaddam, Z. N., Reinhardt, E. K., Thurm, A. E., Potter, B. K., Smith, M., Graham, C., Tiller, B. H., Baker, S. A., Bilder, D. A., Bogar, R., et al. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03900-3 · Cited by 5
“Our findings are reported in accordance with the COS Standard for Reporting statement (Supplemental 1) [59].”
Russell, G., Rana, N., Watts, R., Roshny, S., Siddiqi, N., & Rose, L. (2022) · Age and Ageing · doi:10.1093/ageing/afac267 · Cited by 5
Harman, N., Gorst, S. L., Williamson, P. R., Barnathan, E. S., Baughman, R. P., Judson, M. A., Junk, H., Kampstra, N. A., Sullivan, E. J., Victorson, D. E., et al. (2022) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v39i3.12319 · Cited by 5
Self-citationA Foundation for Patient-Centered Core Impact Sets: Key Learnings from Past and Existing Approaches
Perfetto, E. M., Love, T. R., Oehrlein, E. M., Schoch, S. C., Schrandt, S., Black, H. L., Bright, J. L., Brooke, N. J., Burke, L. B., Coetzee, T., et al. (2023) · Patient · doi:10.1007/s40271-023-00630-1 · Cited by 5
“Both facilitate transparency and rigorous methodology, but neither speak specifically to describing patient engagement and documenting how patients guided COS development [50, 51].”
BackgroundSelf-citationUptake of the core outcome set on polycystic ovary syndrome before and after its publication
Li, W., Li, G., Chi, H., Wang, H., & Zeng, L. (2023) · Human Reproduction · doi:10.1093/humrep/dead149 · Cited by 6
“Previous studies showed that despite the rapid development of COSs, the clarity of reporting of core outcomes was suboptimal and numerous COSs still require improvement (Kirkham et al. , 2016; Gargon et al. , 2019; Goren et al. , 2023).”
Sibert, N. T., Soff, J., Ferla, S. L., Quaranta, M., Kremer, A., & Kowalski, C. (2024) · Cancers · doi:10.3390/cancers16112069 · Cited by 7
“Initiatives such as the International Consortium for Health Outcomes Measurement (ICHOM) [4], Core Outcome Measures for Effectiveness Trials (COMET) [5] or the COS-STAR [6] statement underscore the importance of using similar data collections from a data content’s perspective.”
BackgroundJacobsen, P. C., Berry, K., Clarkson, L., Hiscocks, R., Hopkins, I., Morgan, C., Tandon, D., Teale, A., Tyler, N., & Wood, L. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06294-x · Cited by 6
“This paper is written in line with reporting guidelines for COS development (COS-STAR; [26]).”
Gorst, S. L., Bouhassira, D. C. G., & Turnbull, A. E. (2025) · CHEST Critical Care · doi:10.1016/j.chstcc.2025.100128 · Cited by 5
“Multiple, overlapping, published guidelines exist on how to report the results of Delphi and modified Delphi studies in the health sciences, 25–27 including the Core Outcome Set Standards for Reporting statement, which was developed specifically for reporting on COS development.”
Self-citationGonçalves, A., Marques, A. S. P. D. D., Demain, S. H., & Samuel, D. (2018) · International Journal of Therapy and Rehabilitation · doi:10.12968/ijtr.2018.25.7.346 · Cited by 5
“The COS-STAR statement therefore recommends that COS protocols are made publically available to increase the transparency of the COS development and minimise any biases (Kirkham et al., 2016).”
BackgroundDai, X., Zi, M.-J., Liu, C. X., Wang, Y. M., & Gao, R. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1025833 · Cited by 5
Deshmukh, S. R., Kirkham, J. J., & Karantana, A. (2023) · Bone & Joint Open · doi:10.1302/2633-1462.42.bjo-2022-0105.r1 · Cited by 7
Self-citationGallagher, K., Chant, K., Mancini, A., Bluebond‐Langner, M., & Marlow, N. (2023) · BMC Palliative Care · doi:10.1186/s12904-023-01326-x · Cited by 5
Musabyemungu, J. A., Willson, A., Batenhorst, S., Webbe, J., & Cartledge, P. (2019) · Maternal Health Neonatology and Perinatology · doi:10.1186/s40748-019-0106-8 · Cited by 6
Richardson, M., Kirkham, J. J., Dwan, K. M., Sloan, D. J., Davies, G., & Jorgensen, A. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030212 · Cited by 5
“This threshold for consensus has been used previously in the development of the COS-STAR reporting guideline.(8)”
MethodSelf-citationAn Expert Consensus Study for Informed Consent in Primary Breast Augmentation Surgery
Hagopian, C. O. P., Hagopian, T. M., Wolfswinkel, E. M., Ades, T. B., & Stevens, W. G. (2020) · Aesthetic Surgery Journal · doi:10.1093/asj/sjaa341 · Cited by 5
Hallas, S., Nelson, E. A., O’Meara, S., Adderley, U. J., Meskell, P., Nixon, J., O’Loughlin, A., Probst, S., Tawfick, W. A., Wild, T., et al. (2021) · Journal of Tissue Viability · doi:10.1016/j.jtv.2021.03.005 · Cited by 5
Xiao, L., Shi, L., Liu, S., Luo, Y., Tian, J., & Zhang, L. (2021) · Trials · doi:10.1186/s13063-021-05820-6 · Cited by 5
“We will develop the COS based on the general guidelines of the COMET handbook [20], COSSTAD [21], and consensus-based standards for the selection of health measurement instruments (COSMIN) [22].”
BackgroundMethodMacLennan, S., Wintner, L. M., Beyer, K., Lawlor, A., Tripathee, S., Dabestani, S., Marconi, L. S., Giles, R. H., Woodward, R., Hemelrijck, M. V., et al. (2023) · BJUI Compass · doi:10.1002/bco2.266 · Cited by 5
Metadata
- Authors
- Kirkham, J. J., Gorst, S., Altman, D. G., Blazeby, J. M., Clarke, M., Devane, D., Gargon, E., Moher, D., Schmitt, J., Tugwell, P., Tunis, S., & Williamson, P. R.
- Affiliations
- University of Liverpool (GB)
- University of Oxford (GB)
- University of Bristol (GB)
- Queen's University Belfast (GB)
- Ollscoil na Gaillimhe – University of Galway (IE)
- Ottawa Hospital Research Institute (CA)
- Zentrum für Evidenzbasierte Gesundheitsversorgung (DE)
- University of Ottawa (CA)
- Center for Medical Technology Policy (US)
- Corresponding author
- Williamson, Paula R.
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-10-18
- Volume
- 13
- Issue
- 10
- Pages
- e1002148
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5068732
- OpenAlex
- W2534322213
- Cited by
- 650
- References
- 25
- Citations by year
- 2026: 63 · 2025: 89 · 2024: 75 · 2023: 63 · 2022: 83 · 2021: 71 · 2020: 69 · 2019: 50 · 2018: 47 · 2017: 38 · 2016: 2
- FWCI
- 130.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Research Explorer (The University of Manchester) (submittedVersion, other-oa)
- Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- Explore Bristol Research (submittedVersion, cc-by)
- Funders
- Cincinnati Children's Hospital Medical Center
- University of Minnesota
- Loyola University Chicago
- University of Washington
- McGill University
- Shandong University
- National Institute for Health and Care Excellence
- Health Research Board (TMRN-2014-1)
- Sidra Medicine
- Cancer Research UK (16895)
- National Institute for Health and Care Research (NF-SI-0513-10025)
- University of Warwick
- University of Bath
- University of Bristol
- Trinity College Dublin
- Universitat de València
- Tampereen Yliopisto
- Universidad de Chile
- Université François-Rabelais
- Université de Versailles Saint-Quentin-en-Yvelines
- Medical Research Council (MR/L004933/1, MR/L004933/2, MR/K025635/1)
- Topics
- Social Sciences › Sociology and Political Science › Delphi Technique in Research
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- core outcome set, reporting guidelines, reporting transparency, outcome measurement, stakeholder engagement, Delphi consensus, low- and middle-income countries, healthcare decision-making
- MeSH terms
- Consensus Development Conferences as Topic, Consensus Statements as Topic, Review Literature as Topic, Outcome Assessment, Health Care, Guidelines as Topic, Biomedical Research, Checklist
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.